Algeta Schedules Third Quarter 2013 Results Presentation, Webcast and Conference Call

        Print
| Source: Algeta ASA

OSLO, Norway, Oct. 28, 2013 (GLOBE NEWSWIRE) --

Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, will announce its third
quarter 2013 results on Wednesday, 6 November 2013. A presentation by members of
Algeta's executive management team to investors, analysts and the press will
take place in Oslo at 10:00 CET.

The  presentation  will  also  be  webcast  live  and  can  be  accessed through
www.algeta.com where questions can also be submitted during the presentation.

The presentation will take place at 10:00 CET at:

KS-Agenda Møtesenter
Haakon VIIs gate 9
0161 Oslo
Norway.

At  14:30 CET/08:30 Eastern Time,  Algeta's executive management  team will also
host an international conference call.

To  participate in the conference call, please dial the appropriate number below
five minutes prior to the call:

US: +1 877 423 0830
UK: +44 20 7153 9154
Norway: +47 21 06 61 13
Sweden: +46 8-506 443 86
Denmark: +45 32 71 42 62
Switzerland: +41 44 580 65 22

Participant pin code: 873878#


To access the replay, please dial:

US: +1 877 679 2989
UK: +44 203 364 5200
Norway: +47 23 50 02 03
Sweden: +46 8-505 564 73

Conference reference: 348995#

A replay of the conference call will also be available at www.algeta.com.

The  results report and the presentation  will be available at www.algeta.com in
the Investors section from 07:00 CET.


                                      ###



For further information, please contact:

  Mike Booth                             +1 646 410 1884

  Communications & Corporate Affairs     ir@algeta.com



  Media enquiries:

  Mark Swallow                           +44 207 638 9571

  Citigate Dewe Rogerson                 mark.swallow@citigatedr.co.uk



  Knut Ekern                             +47 22 04 82 00

  Gambit Hill & Knowlton                 knut.ekern@hkstrategies.com



  Kari Watson                            +1 781 235 3060

  MacDougall Biomedical Communications   kwatson@macbiocom.com



  Investor enquiries:

  Tricia Truehart                        +1 646 378 2953

  The Trout Group                        ttruehart@troutgroup.com



About Algeta

Algeta is a company focused on developing, manufacturing and marketing novel
targeted therapies for patients with cancer. The Company is headquartered in
Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA
performing commercial marketing operations in the US. Algeta is listed on the
Oslo Stock Exchange (Ticker: ALGETA). For more information please visit
www.algeta.com.


Press release: http://hugin.info/134655/R/1738456/583160.pdf

[HUG#1738456]